Clinical Trial Details

NCT ID: NCT02781675
Date Last Changed: May 26, 2016


Research Study Summary

A clinical research study of Dietary Intervention for the treatment of Cardiovascular Disease, Dyslipidemia or Inflammation

Research Study Title

Effects of a Modified High-fat Mediterranean Dietary Pattern on Lipoprotein and Inflammatory Markers of CVD Risk in Adults


A Mediterranean dietary pattern emphasizing an abundance of plant-based foods including nuts, moderate intakes of fish, poultry and low-fat dairy products, and use of extra virgin olive oil as the main source of fat has been associated with reduced risk of cardiovascular disease (CVD), and such a pattern has been advocated by the 2015 U.S. Dietary Guidelines Advisory Committee. The strongest experimental support for this recommendation derives from the success of the recent PREDIMED CVD outcomes trial, and studies indicating that a Mediterranean-style diet improves lipoprotein and oxidative markers of cardiovascular disease risk in comparison to either low-fat or Western dietary patterns. However, in none of these studies were comparisons made between the effects of Mediterranean-style diets with low-/nonfat vs. full-fat dairy foods. The overall objective of the present proposal is to determine whether the inclusion of full-fat rather than low- and nonfat dairy foods in a Mediterranean dietary pattern based on that used in the PREDIMED study results in similar improvements in biomarkers of CVD risk. Specifically, we will test the hypotheses that 1) a standard Mediterranean diet will lower LDL-C and apoB compared to a Western diet; 2) modification of the Mediterranean diet by replacing low-fat dairy products with high-fat dairy (3 servings/day; high-dairy fat Mediterranean diet) will not significantly increase LDL-C and apoB but may raise large buoyant LDL particles compared with a standard Mediterranean diet; and 3) the high dairy fat and standard Mediterranean diets will result in comparable reductions in levels of inflammatory markers and oxidized LDL, and improvements in endothelial function compared to a Western diet.

To Learn more

Recruitment Details

21 and up
Overall Status
Lead Sponsor
Children's Hospital & Research Center Oakland
19 Months
Facility Type


All ages 21 Years and up

Inclusion Criteria:

  • BMI 25-35 kg/m2

  • Weight stable for > 3 months

  • Agrees to abstain from alcohol or dietary supplements during the study

Exclusion Criteria:

  • History of coronary heart disease, cerebrovascular disease, peripheral vascular disease, bleeding disorder, liver or renal disease, diabetes, lung disease, HIV, or cancer (other than skin cancer) in the last 5 years.

  • Current use of hormones or drugs knowns to affect lipid metabolism

  • Use of nicotine products or recreational drugs

  • Abnormal TSH

  • Pregnant or breastfeeding

  • Total- and LDL- cholesterol > 95th percentile for sex and age

  • Fasting triglyceride > 500 mg/dl

  • Fasting blood sugar > 126 mg/dl

  • Blood pressure > 160/95 mm Hg

  • Allergy to or unwillingness to consume study foods

Site Locations (1)

Country State City Zip Facility and Contact
United States California Berkeley 94705 Cholesterol Research Center
Megan Bennett

Ronald M Krauss, MD
Principal Investigator


Megan Bennett

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.